EZH1 and glioblastoma: Furthermore, to clarify whether enhanced H3K27me3 contributes to glial induction of GBM cells, we applied the selective H3K27me3 histone demethylase inhibitor GSK J1 and the selective EZH1/2 inhibitor EPZ005687.